Recent advances in epilepsy management

Lia D. Ernst, Eilis Boudreau

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Purpose of review Recent advances in our understanding of seizure generation have resulted in modified recommendations for when seizure treatment should be initiated, revisions to our definition of status epilepticus, and new pharmacological and neuromodulatory therapies. The goal of this review is to provide the anesthesiologist with an overview of the advancements they are most likely to encounter while providing clinical care. Recent findings There have been recent modifications to seizure definitions and treatment recommendations. These include the idea that treatment with antiepileptic therapy should be initiated after the first unprovoked seizure in individuals who are at high risk for another seizure, and that the idea that status epilepticus should be thought of as a twophase process, related to an initial phase after which intervention should be started, and a second phase after which time risk of long-Term sequelae is increased. Additionally, several new therapies have become available that have novel mechanisms of action, which are more efficacious and have fewer side-effects. Summary As knowledge about mechanisms of seizure generation has improved, there has been a concurrent evolution in our thinking about seizure-related definitions, and indications for initiation of treatment. Several next generation drug therapies with more specific targets have also become available. Taken together, there have been significant improvements in care options.

Original languageEnglish (US)
Pages (from-to)558-562
Number of pages5
JournalCurrent Opinion in Anaesthesiology
Volume29
Issue number5
DOIs
StatePublished - 2016

Fingerprint

Epilepsy
Seizures
Status Epilepticus
Therapeutics
Anticonvulsants
Pharmacology
Drug Therapy

Keywords

  • Antiepileptic drug
  • Neurostimulation
  • Seizure
  • Status epilepticus

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Recent advances in epilepsy management. / Ernst, Lia D.; Boudreau, Eilis.

In: Current Opinion in Anaesthesiology, Vol. 29, No. 5, 2016, p. 558-562.

Research output: Contribution to journalReview article

Ernst, Lia D. ; Boudreau, Eilis. / Recent advances in epilepsy management. In: Current Opinion in Anaesthesiology. 2016 ; Vol. 29, No. 5. pp. 558-562.
@article{e384c46458d24fc59000454843b17a77,
title = "Recent advances in epilepsy management",
abstract = "Purpose of review Recent advances in our understanding of seizure generation have resulted in modified recommendations for when seizure treatment should be initiated, revisions to our definition of status epilepticus, and new pharmacological and neuromodulatory therapies. The goal of this review is to provide the anesthesiologist with an overview of the advancements they are most likely to encounter while providing clinical care. Recent findings There have been recent modifications to seizure definitions and treatment recommendations. These include the idea that treatment with antiepileptic therapy should be initiated after the first unprovoked seizure in individuals who are at high risk for another seizure, and that the idea that status epilepticus should be thought of as a twophase process, related to an initial phase after which intervention should be started, and a second phase after which time risk of long-Term sequelae is increased. Additionally, several new therapies have become available that have novel mechanisms of action, which are more efficacious and have fewer side-effects. Summary As knowledge about mechanisms of seizure generation has improved, there has been a concurrent evolution in our thinking about seizure-related definitions, and indications for initiation of treatment. Several next generation drug therapies with more specific targets have also become available. Taken together, there have been significant improvements in care options.",
keywords = "Antiepileptic drug, Neurostimulation, Seizure, Status epilepticus",
author = "Ernst, {Lia D.} and Eilis Boudreau",
year = "2016",
doi = "10.1097/ACO.0000000000000376",
language = "English (US)",
volume = "29",
pages = "558--562",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Recent advances in epilepsy management

AU - Ernst, Lia D.

AU - Boudreau, Eilis

PY - 2016

Y1 - 2016

N2 - Purpose of review Recent advances in our understanding of seizure generation have resulted in modified recommendations for when seizure treatment should be initiated, revisions to our definition of status epilepticus, and new pharmacological and neuromodulatory therapies. The goal of this review is to provide the anesthesiologist with an overview of the advancements they are most likely to encounter while providing clinical care. Recent findings There have been recent modifications to seizure definitions and treatment recommendations. These include the idea that treatment with antiepileptic therapy should be initiated after the first unprovoked seizure in individuals who are at high risk for another seizure, and that the idea that status epilepticus should be thought of as a twophase process, related to an initial phase after which intervention should be started, and a second phase after which time risk of long-Term sequelae is increased. Additionally, several new therapies have become available that have novel mechanisms of action, which are more efficacious and have fewer side-effects. Summary As knowledge about mechanisms of seizure generation has improved, there has been a concurrent evolution in our thinking about seizure-related definitions, and indications for initiation of treatment. Several next generation drug therapies with more specific targets have also become available. Taken together, there have been significant improvements in care options.

AB - Purpose of review Recent advances in our understanding of seizure generation have resulted in modified recommendations for when seizure treatment should be initiated, revisions to our definition of status epilepticus, and new pharmacological and neuromodulatory therapies. The goal of this review is to provide the anesthesiologist with an overview of the advancements they are most likely to encounter while providing clinical care. Recent findings There have been recent modifications to seizure definitions and treatment recommendations. These include the idea that treatment with antiepileptic therapy should be initiated after the first unprovoked seizure in individuals who are at high risk for another seizure, and that the idea that status epilepticus should be thought of as a twophase process, related to an initial phase after which intervention should be started, and a second phase after which time risk of long-Term sequelae is increased. Additionally, several new therapies have become available that have novel mechanisms of action, which are more efficacious and have fewer side-effects. Summary As knowledge about mechanisms of seizure generation has improved, there has been a concurrent evolution in our thinking about seizure-related definitions, and indications for initiation of treatment. Several next generation drug therapies with more specific targets have also become available. Taken together, there have been significant improvements in care options.

KW - Antiepileptic drug

KW - Neurostimulation

KW - Seizure

KW - Status epilepticus

UR - http://www.scopus.com/inward/record.url?scp=84983488721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983488721&partnerID=8YFLogxK

U2 - 10.1097/ACO.0000000000000376

DO - 10.1097/ACO.0000000000000376

M3 - Review article

VL - 29

SP - 558

EP - 562

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

IS - 5

ER -